Related Experiment Video

Updated: Apr 5, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

13.1K

A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway

Emine Guven-Maiorov1, Ozlem Keskin1, Attila Gursoy2

  • 1Department of Chemical and Biological Engineering, Koc University, Istanbul, Turkey; Center for Computational Biology and Bioinformatics, Koc University, Istanbul, Turkey.

Biophysical Journal
|August 16, 2015
PubMed

Insights

Toll-like receptor (TLR) pathway regulation is crucial for preventing devastating inflammation. This study reveals structural insights into how protein interactions and deubiquitinases inhibit TLR signaling, with mutations causing chronic inflammation and disease.

Area of Science:

  • Immunology
  • Structural Biology
  • Molecular Biology

Background:

  • Toll-like receptor (TLR) signaling is vital for innate immunity but requires tight regulation to prevent excessive inflammatory responses.
  • Existing knowledge on the precise mechanisms of TLR signaling inhibition, particularly involving protein-protein interactions and ubiquitination, remains incomplete.

Purpose of the Study:

  • To elucidate the structural basis for the regulation of Toll-like receptor (TLR) signaling pathways.
  • To investigate how protein-protein interactions and deubiquitinases control TLR signalosome formation and downstream signaling.
  • To analyze the impact of oncogenic mutations on negative regulators of TLR signaling and their role in inflammation and disease.

Main Methods:

  • Construction and analysis of protein-protein interaction architectures.
  • Structural data analysis to identify regulatory mechanisms.
  • In silico mutagenesis analysis to assess the effects of mutations on protein interactions and signaling outcomes.

Main Results:

  • Toll/IL-1R (TIR) domain-containing regulators disrupt TIR domain signalosome assembly.
  • Deubiquitinases (e.g., A20, CYLD, DUBA) prevent key protein associations and remove regulatory ubiquitin chains.
  • Alternative TLR pathways compete for binding partners, further restricting signaling.
  • Oncogenic mutations in negative regulators disrupt interactions, leading to constitutive NF-κB activation and inflammation.

Conclusions:

  • Structural insights reveal multiple layers of negative regulation in TLR signaling.
  • Disruption of these regulatory mechanisms by mutations contributes to chronic inflammation, autoimmune diseases, and cancer.
  • Understanding these pathways is critical for developing therapeutic strategies against TLR-mediated diseases.

More Related Videos

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

8.0K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.1K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.0K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
19.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K